Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

The SARS-CoV-2 spike protein receptor-binding domain expressed in rice callus features a homogeneous mix of complex-type glycans

  • Sobrino-Mengual, Guillermo
  • Armario-Najera, Victoria
  • Balieu, Juliette
  • Walet-Balieu, Marie-Laure
  • Saba-Mayoral, Andrea
  • Pelacho Aja, Ana Mª
  • Capell Capell, Teresa
  • Christou, Paul
  • Bardor, Muriel
  • Lerouge, Patrice
The spike protein receptor-binding domain (RBD) of SARS-CoV-2 is required for the infection of human cells. It is the main target that elicits neutralizing antibodies and also a major component of diagnostic kits. The large demand for this protein has led to the use of plants as a production platform. However, it is necessary to determine the N-glycan structures of an RBD to investigate its efficacy and functionality as a vaccine candidate or diagnostic reagent. Here, we analyzed the N-glycan profile of the RBD produced in rice callus. Of the two potential N-glycan acceptor sites, we found that one was not utilized and the other contained a mixture of complex-type N-glycans. This differs from the heterogeneous mixture of N-glycans found when an RBD is expressed in other hosts, including Nicotiana benthamiana. By comparing the glycosylation profiles of different hosts, we can select platforms that produce RBDs with the most beneficial N-glycan structures for different applications., : We acknowledge funding from the Spanish Ministry of Science and Innovation MCIN/AEI/ 10.13039/501100011033/FEDER EU to project PID2022-1414160B-I00 and by Generalitat de Catalunya Grant 2021 SGR 01501 to the Agricultural Biotechnology and Bioeconomy Unit (ABBU). This research was funded by the European Union’s Horizon 2020 Research and Innovation Program through the Pharma-Factory project under Grant No. 774078. This work was also financially supported by the French government through the ANR agency under the ANR PRCE DAGENTA project (ANR-21- CE20-0038-001) and the program «Grand défi Biomédicament: améliorer les rendements et maîtriser les coûts de production: Nouveaux Systèmes d’Expression—2020» (PHAEOMABS project—ANR-21- F2II-0005). We acknowledge the Spanish Ministry of Science, Innovation and Universities for their FPI fellowship PRE2019-088852 given to GSM.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The SARS-CoV-2 spike protein receptor-binding domain expressed in rice callus features a homogeneous mix of complex-type glycans

  • Sobrino-Mengual, Guillermo
  • Armario-Najera, Victoria
  • Balieu, Juliette
  • Walet-Balieu, Marie-Laure
  • Saba-Mayoral, Andrea
  • Pelacho Aja, Ana Mª
  • Capell Capell, Teresa
  • Christou, Paul
  • Bardor, Muriel
  • Lerouge, Patrice
The spike protein receptor-binding domain (RBD) of SARS-CoV-2 is required for the infection of human cells. It is the main target that elicits neutralizing antibodies and also a major component of diagnostic kits. The large demand for this protein has led to the use of plants as a production platform. However, it is necessary to determine the N-glycan structures of an RBD to investigate its efficacy and functionality as a vaccine candidate or diagnostic reagent. Here, we analyzed the N-glycan profile of the RBD produced in rice callus. Of the two potential N-glycan acceptor sites, we found that one was not utilized and the other contained a mixture of complex-type N-glycans. This differs from the heterogeneous mixture of N-glycans found when an RBD is expressed in other hosts, including Nicotiana benthamiana. By comparing the glycosylation profiles of different hosts, we can select platforms that produce RBDs with the most beneficial N-glycan structures for different applications., : We acknowledge funding from the Spanish Ministry of Science and Innovation MCIN/AEI/ 10.13039/501100011033/FEDER EU to project PID2022-1414160B-I00 and by Generalitat de Catalunya Grant 2021 SGR 01501 to the Agricultural Biotechnology and Bioeconomy Unit (ABBU). This research was funded by the European Union’s Horizon 2020 Research and Innovation Program through the Pharma-Factory project under Grant No. 774078. This work was also financially supported by the French government through the ANR agency under the ANR PRCE DAGENTA project (ANR-21- CE20-0038-001) and the program «Grand défi Biomédicament: améliorer les rendements et maîtriser les coûts de production: Nouveaux Systèmes d’Expression—2020» (PHAEOMABS project—ANR-21- F2II-0005). We acknowledge the Spanish Ministry of Science, Innovation and Universities for their FPI fellowship PRE2019-088852 given to GSM.